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Abstract
Background: Although depression has been regarded as a major public health problem, many individuals with depression still
remain undetected or untreated. Despite the potential for Internet-based tools to greatly improve the success rate of screening
for depression, their reliability and validity has not been well studied. Therefore the aim of this study was to evaluate the test-
retest reliability and criterion validity of a Web-based system, the Internet-based Self-assessment Program for Depression (ISP-
D).
Methods: The ISP-D to screen for major depressive disorder (MDD), minor depressive disorder (MinD), and subsyndromal
depressive symptoms (SSD) was developed in traditional Chinese. Volunteers, 18 years and older, were recruited via the
Internet and then assessed twice on the online ISP-D system to investigate the test-retest reliability of the test. They were
subsequently prompted to schedule face-to-face interviews. The interviews were performed by the research psychiatrists using
the Mini-International Neuropsychiatric Interview and the diagnoses made according to DSM-IV diagnostic criteria were used
for the statistics of criterion validity. Kappa (κ) values were calculated to assess test-retest reliability.
Results: A total of 579 volunteer subjects were administered the test. Most of the subjects were young (mean age: 26.2 ± 6.6
years), female (77.7%), single (81.6%), and well educated (61.9% college or higher). The distributions of MDD, MinD, SSD and
no depression specified were 30.9%, 7.4%, 15.2%, and 46.5%, respectively. The mean time to complete the ISP-D was 8.89 ±
6.77 min. One hundred and eighty-four of the respondents completed the retest (response rate: 31.8%). Our analysis revealed
that the 2-week test-retest reliability for ISP-D was excellent (weighted κ = 0.801). Fifty-five participants completed the face-
to-face interview for the validity study. The sensitivity, specificity, positive, and negative predictive values for major depressive
disorder were 81.8% and 72.7%, 66.7%, and 85.7% respectively. The overall accuracy was 76.4%.
Conclusion: The evidence indicates the ISP-D is a reliable and valid online tool for assessing depression. Further studies should
test the ISP-D in clinical settings to increase its applications in clinical environments with different populations and in a larger
sample size.
Published: 10 April 2007
BMC Psychiatry 2007, 7:12 doi:10.1186/1471-244X-7-12
Received: 31 August 2006
Accepted: 10 April 2007
This article is available from: http://www.biomedcentral.com/1471-244X/7/12
© 2007 Lin et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Psychiatry 2007, 7:12 http://www.biomedcentral.com/1471-244X/7/12
Page 2 of 9
(page number not for citation purposes)
Background
Clinical depression is a highly prevalent mental illness.
The World Health Organization Global Burden of Disease
study in 1997 predicted that clinical depression will be the
second most burdensome illness in the world by the year
2020 [1]. The prevalence of depressive symptoms is high,
ranging from 20% to 41% of the total population [2,3].
The prevalence of major depressive disorder (MDD) and
subsymdormal depressive (SSD) symptoms in an Austral-
ian population were found to be 6.8% and 12.9%, respec-
tively [4]. Prevalence of minor depressive disorder
(MinD) has been reported to be in the range of 2.6% to
4.5% [5]. Depression is associated with considerably high
mortality through suicide, medical illness, and increased
risk of accidental death [6]. The high prevalence of depres-
sion, together with its significant morbidity, potential
treatability, and costs, has made improved detection and
management a priority for policymakers and health care
agencies [7]. Nevertheless many individuals with depres-
sion remain undetected or go untreated [8]. Screening is a
frequently proposed strategy for increasing detection of
depression; however the diagnostic rate for depression by
primary care practitioners is low [9-12]. Many primary
care providers fail to diagnose depression in their patients
either because they do not know how to screen for depres-
sion, have insufficient time, prefer not to label a patient
with a mental illness, or do not know how to proceed with
a positive result [13]. Furthermore, the current cost of
screening for depression may be too high relative to the
projected benefit in quality-adjusted life years (QALYs)
for many countries to implement. For example, Valen-
stein et al. found that the cost of screening every 5 years or
of one-time screening were $50,988/QALY and $32,053/
QALY, respectively [7]. These obstacles impede the
progress of screening for depression, which may result in
delayed assessment or treatment of the disease. Such
delays in diagnosis and treatment can ultimately result in
profound consequences for patients including great finan-
cial costs, and disruption of interpersonal relationships
and employment, as well as diminished overall mental
and physical health. For these reasons, it is important to
consider programs that can assess risk of depression in a
manner that is easier, less costly, and more confidential
than the face-to-face interview.
Computer-administered depression assessment pro-
grams, such as the computer-administered version of the
Hamilton Depression Rating Scales [14], the computer-
ized version of the Center for Epidemiological Studies
Depressed Mood Scale (CES-D) [15], the computer-adap-
tive test for depression (D-CAT) [16], and the electronic
version of Mini-International Neuropsychiatric Interview
(M.I.N.I.) [17] have been developed in recent years. They
give standardized information about a patient's psycho-
pathology [18], and could reduce both the time and the
tremendous financial cost of processing and analyzing
diagnostic data [19]. Previous researches have indicated
that patients preferred the computer-mediated to the cli-
nician interviews for assessment in sensitive areas such as
suicide, substance abuse, sexual behavior, and HIV-
related symptoms. Patients felt less embarrassed, more
relaxed, and were generally more honest when using com-
puter assessments [20-23]. Despite the wealth of encour-
aging research, few computer aids are being used in
regular mental health care in nonresearch settings. One of
the reasons for this may be that computer-administered
programs still require that people come to a clinical set-
ting to take the test.
The Internet provides advantages that may greatly
improve the utility of computer-administered diagnostic
programs. Firstly, Web-based programs are an anony-
mous method of accessing information about socially
"unacceptable" illnesses [19]. Furthermore Internet pro-
grams can reach a large number of individuals across a
broad geographic area at a low cost, and may also identify
many persons who have never received treatment [24].
Individuals may surf the Internet conveniently to find
information about whether they have depression or
whether they should seek treatment. There are several pro-
grams through which people may be assessed for depres-
sion through the Internet, including an Internet-based
depression screening test adapted from the CES-D scale
[24] and the Web-Based Depression and Anxiety Test
(WB-DAT) [25].
Because they are anonymous, Internet studies are difficult
to perform. As yet, only one study has made an attempt to
evaluate the validity of a Web-based instrument for
depression [25]. In that study, the researchers reported
that the WB-DAT had good diagnostic concordance with
Structured Clinical Interview for DSM-IV Axis I Disorders
(SCID-I/P) diagnosis for MDD. However, the participants
in the sample were recruited from several clinical research
projects, a subject population that is not representative of
Internet users at large. No previous academic reports
could be found on the reliability of such programs. In the
present study, we describe the design of the Internet-based
Self-assessment Program for Depression (ISP-D) and eval-
uate the test-retest reliability and criterion validity of the
ISP-D.
Methods
System and program design
The ISP-D was developed by a committee consisting of 16
certified psychiatrists in Taiwan. Its aim is to provide
Internet users a concise, interactive, and individualized
tool to self-assess depressive symptoms and screen for
depressive disorders. It included 3 depression diagnoses:
MDD, MinD, and SSD. These three diagnoses were chosenBMC Psychiatry 2007, 7:12 http://www.biomedcentral.com/1471-244X/7/12
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because they include the same nine symptoms and they
represent different levels of depression severity. MDD was
defined in the DSM-IV criteria [26]. MinD was defined in
accordance with the DSM-IV research criteria, that is, an
episode with depressed mood or decreased interest, fulfill-
ing at least two (but fewer than five) A criteria for a major
depressive disorder [26,27]. SSD was used to evaluate sub-
threshold depression, which was defined as having two or
more symptoms of depression criteria excluding the A cri-
teria [27-29]. The presence of each symptom was deter-
mined using one to three questions, which were adapted
primarily from the M.I.N.I. [17], and Taiwanese Depres-
sion Questionnaire (TDQ) [30]. Some revisions were
made to improve understanding and readability on the
Internet browser, e.g. more explanations or examples were
included and different font colors or styles were incorpo-
rated to highlight important messages. Because the pro-
gram was designed with branching, different users may
get different numbers of questions (9 to 24) during a com-
plete assessment.
The interactive ISP-D system was hosted on a Microsoft
Windows 2000 server of PsychPark [31] in Taiwan and
developed with Active Server Page 3.0 and HTML 3.0. The
database system was constructed with a Microsoft SQL
server 2000. Visual Basic (VB) script was used for interac-
tive program and real-time data analysis to confirm that
all questions had been completed. The Web site and Sim-
ple Mail Transfer Protocol (SMTP) service were hosted on
Internet Information Services (IIS) 5.0. The transmission
of account/password was protected by Secure Sockets
Layer on the server. PsychPark, one of the largest and most
popular mental health websites among the Chinese pop-
ulation, was established in 1995 as a virtual organization.
PsychPark is free and membership is open to the general
population.
Participants
Participants were volunteers recruited via the Internet.
They found the study advertisement on PsychPark, which
was listed on the Web resources of major portal websites,
such as Yahoo and MSN. During the recruitment period,
weekly electronic papers were sent to the subscribers of
PsychPark e-paper. Individuals who wanted to know
whether they had depressive disorders or wanted to
recheck their existing depressive disorders were encour-
aged to join the study [32]. The only inclusion criterion
was that participants must be at least 18 years of age
because the program was not designed to assess adoles-
cent depression. Participants were excluded if they could
not complete the study protocol. The study was approved
by the Institute Review Board of the Yuli Veterans Hospi-
tal, Taiwan and was performed in compliance with the
Helsinki Declaration.
Procedure
Recruitment for the ISP-D test-retest reliability study was
performed from September 2001 to January 2002. The
entire process of the reliability study was completed via
the Internet. When a participant entered the study web-
site, the program began with an introduction about the
aims and the procedure of the study. Each participant had
to set up a PsychPark user account and password online to
participate in the study, and was asked to visit a real clinic
as soon as possible if he/she faced a severe mental condi-
tion. After reading a complete description of the study on
the browser, the participant signed an informed consent
form. Each participant was then asked questions on his or
her sociodemographic data. There were brief instructions
on how to answer subsequent questions about depressive
symptoms and related conditions. We encouraged the
participants to answer the questions honestly so that their
assessment would achieve more accurate results.
The algorithm for performing the ISP-D test is shown in
Figure 1. Most of the questions had multiple correspond-
ing choices of answers and participants simply clicked to
choose their answer (Additional File 1). Total interview
times were recorded. About one to two weeks after the
completion of the test, we sent follow-up e-mail messages
to notify the participants to perform the ISP-D test again.
We sent another e-mail message to respondents that had
not performed the retest within 2 weeks of the first follow-
up email notice. Participants' identifying PsychPark
accounts precluded them from repeating the ISP-D test
without permission before the minimal re-test interval.
After completing the self-administered assessments, the
participants were asked to make an appointment with a
psychiatrist of our research team near his/her location for
the validity study. Our research team included 16 certified
psychiatrists who were located in most of the geographic
areas of Taiwan. The psychiatrists had been trained to use
the M.I.N.I. [17], a clinical diagnostic interview based on
the DSM-IV. They performed face-to-face semi-structured
interviews with the M.I.N.I. and made psychiatric diag-
noses according to the DSM-IV. Recruitment for the valid-
ity study was performed from September 2001 to May
2002 [33].
Data analysis
Subjects were classified as having MDD, MinD, SSD, or as
no depression specified (ND). The system's test-retest reli-
ability was analyzed by computing weighted kappa (κ)
statistics for various time intervals. In order to examine
the test-retest reliability for each diagnosis, κ values were
recalculated for the groupings of MDD vs. non-MDD,
MinD vs. non-MinD, and SSD vs. non-SSD. The test-retest
reliability for each depressive symptom was calculated
using the same method. To analyze the representation ofBMC Psychiatry 2007, 7:12 http://www.biomedcentral.com/1471-244X/7/12
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our retest sample, sociodemographic data were compared
between the retest responders and non-responders. To
analyze the variables affecting test-retest agreement, we
compared the sociodemographic data between partici-
pants with test-retest agreement and those without agree-
ment.
The psychiatrist's diagnosis was regarded as the criterion
for the validity statistics. Validity statistics included sensi-
tivity, specificity, positive predictive value (PPV), and neg-
ative predictive value (NPV). To analyze the
representation of our validity sample, sociodemographic
data were compared between participants entering the
validity study (validity sample) and those not entering the
validity study (non-validity sample). To analyze the varia-
bles affecting the agreement between the diagnoses of ISP-
D and psychiatrists, we compared the sociodemographic
data between participants with agreement and those with-
out agreement.
A Chi-square test was used to compare categorical varia-
bles and t-tests were used to compare continuous varia-
Algorithm for Internet-based Self-assessment Program for Depression Figure 1
Algorithm for Internet-based Self-assessment Program for Depression. Dashed line indicates that the function was 
not implemented until the study was completed.BMC Psychiatry 2007, 7:12 http://www.biomedcentral.com/1471-244X/7/12
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bles between group pairs. Standard deviations were
calculated for all mean values. A p value of <0.05 (two-
tailed) was considered significant for all statistical tests.
The statistical software used was SPSS 10.0 for Windows.




There were 579 valid participants who completed the ISP-
D test. Their demographic data and characteristics are
summarized in Table 1. The mean age of the study popu-
lation was 26.5 ± 6.6 years and their mean education level
was 14.9 ± 2.1 years. Most of the participants were female
(72.7%), and single (82%). The distributions of MDD,
MinD, SSD, and ND were 30.9% (n = 179), 7.4% (n = 43),
15.2% (n = 88), and 46.5% (n = 269), respectively. The
mean Internet interview time was 8.89 ± 6.77 min.
One hundred and eighty-four of the respondents com-
pleted the retest (response rate: 31.8%). Their diagnostic
distributions of MDD, MinD, SSD, and ND were 39.1%
(n = 72), 8.7% (n = 16), 22.3% (n = 41), and 29.9% (n =
55), respectively. Sociodemographic data between the
retest responders and non-responders did not differ. The
test-retest reliability results calculated by weighted κ were
shown in Table 2 for each of the following time intervals:
within 2 weeks, between 2 and 4 weeks, and greater than
4 weeks. The overall test-retest reliability was excellent
(weighted κ = 0.801) within 2 weeks. The κ values for each
diagnosis within 2 weeks, between 2 and 4 weeks, and
greater than 4 weeks were: MDD (0.830, 0.449, and
0.499), MinD (0.029, 0.197, and 0.316), and SSD (0.812,
0.329, and 0.466). The test-retest reliabilities for each
depressive symptom are shown in Table 3. The test-retest
reliability for each depressive symptom was fair to excel-
lent within a 2-week interval. κ is considered to reflect the
agreement beyond chance. A κ value of at least 0.75 is
regarded as indicative of excellent levels of agreement,
0.60–0.74 as good, 0.40–0.59 as fair, and under 0.40 as
poor agreement [34]. The mean test-retest interval was
21.8 ± 16.7 days. There were no statistically significant dif-
ferences for age, sex, marital status, years of education,
employment, test-retest time interval, or testing time
between participants with test-retest agreement and those
without agreement.
Validity study
Fifty-five participants completed the validity study (1076
ISP-D tests during the study period). Their demographic
characteristics and a comparison between validity sample
and non-validity sample are presented in Table 1. The par-
ticipants in the validity sample were significantly older
than those in the non-validity sample and were more
likely to be employed. The interval between the last ISP-D
test and the psychiatric interview was 5.7 ± 3.9 days. The
mean Internet interview time was 10.29 ± 8.11 min, and
the mean face-to-face psychiatric interview time was 22.4
± 10.7 min. The length of the psychiatric interview was
significantly greater than that of the Internet interview
(paired-t test, t = 6.97, df = 49, p < 0.001). Because psychi-
atrists diagnosed only one participant with MinD and
only one participant with SSD, it was not possible to cal-
culate the validity for MinD and SSD. Therefore, these two
participants were classified as non-MDD and only the
validity of MDD was calculated. A comparison of the ISP-
D diagnoses and psychiatrists' diagnoses is shown in
Table 4. Using the psychiatrist's diagnosis as the criterion,
the ISP-D's accuracy was 76.4%, sensitivity 81.8%, specif-
icity 72.7%, PPV 66.7%, and NPV 85.7%. There were no
statistically significant differences in the sociodemo-
graphic data between participants with diagnostic agree-
ment and those without agreement.
Discussion
In our analysis, the ISP-D was found to be a reliable and
valid tool for Internet users. The reliability and validity of
data collected through the Internet have been questioned
because the data were based on information provided
directly by the patient's experience and data gathering
were administered remotely. In the study, the overall test-
retest reliability for ISP-D was excellent within a 2-week
interval. Regarding the test-retest reliability for each diag-
nosis within a 2-week interval, MDD and SSD were found
to be excellent. Only the reliability of MinD was low,
which may be related to the relatively fewer number of
cases of MinD. It is possible that MinD was not a stable
diagnosis or that it may have been a stage of another
depressive disorder. The high reliability of SSD implied
that its diagnosis is worthy of further studies of validity
and psychopathology. As the test-retest interval increased
to greater than 2 weeks, the test-retest reliabilities of MDD
and SSD decreased. Because MinD has similar sympto-
matic criteria to MDD and SSD, the good reliabilities of
MDD and SSD lessened the possibility of problems with
the questionnaire design or the media bias of the Internet.
The analysis of test-retest reliability for each depressive
symptom showed that the reliabilities for "diminished
interest or pleasure", "fatigue or loss of energy", and
"thoughts of death" were excellent and that those for
other symptoms were fair within a 2-week interval. The
reliabilities were poor only for "depressed mood" and
"thoughts of death" with a time interval between 2 and 4
weeks, and were poor only for "decreased appetite",
"activity disturbance", and "fatigue or loss of energy" with
a time interval greater than 4 weeks. The test-retest relia-
bility with a time interval of greater than 2 weeks may be
affected by the fluctuating course of depressive disorders
themselves. According to Judd et al. [35]., the sympto-BMC Psychiatry 2007, 7:12 http://www.biomedcentral.com/1471-244X/7/12
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matic course of MDD is dynamic and changeable, and
MDD, MinD, and SSD symptom levels commonly alter-
nate over time in the same patients as a symptomatic con-
tinuum of illness activity of a single clinical disease.
Cuijpers and Smit found that the incidence of MDD in
subjects with SSD is larger than in subjects without SSD
[36]. Thus in spite of a possible fluctuating course, the
test-retest reliability of each depressive symptom in the
ISP-D was fair to excellent within a 2-week interval.
For the validity study, the M.I.N.I. was applied in the clin-
ical interview. The concordance between the M.I.N.I. and
SCID-P diagnoses was demonstrated to be very good (sen-
sitivity 96%, specificity 88%, PPV 87%, and NPV 97%)
[17]. κ values of inter-rater reliability for the M.I.N.I. and
for test-retest reliability of MDD were previously reported
to be 1.00 and 0.87, respectively [17], indicating that the
M.I.N.I. is a good criterion for validity. As of yet, only one
study has previously attempted to evaluate the validity of
a Web-based instrument for depression diagnosis [25]. In
that study Farvolden et al. showed that the WB-DAT had
sensitivity, specificity, PPV, and NPV of 79%, 89%, 75%,
and 93%, respectively, relative to SCID-I/P diagnosis for
MDD [25]. Our result is similar to that of Farvolden et al.
and confirms that the Internet may be a valid tool for the
assessment of depression. Farvolden et al.'s study differed
from the present study in that the participants in their
study were recruited from several clinical research projects
and the test was performed in a clinical environment. By
contrast, our study participants were recruited remotely,
directly from the Internet, and the ISP-D was used to eval-
uate depressive disorders with differing severities includ-
ing MDD, MinD, and SSD. All the other validity studies
for depression have been conducted in writing (pen and
paper tests). One such study by Haringsma et al. [37] used
the same assessment tool as that used in our study (the
M.I.N.I.) to assess the criterion validity of the CES-D in a
sample of self-referred seniors. They found that with the
optimal cut-off score of 25 for MDD, sensitivity was 85%,
specificity 64%, and PPN 63%. In Bagby's review article
[38], the mean sensitivity, specificity, PPV, and NPV of the
Hamilton Depression Rating Scale from 7 studies were
found to be 76%, 91%, 77%, and 92%, respectively. In
Nyklicek's study [39] of the Edinburgh Depression Scale
(EDS) with 951 randomly selected women of peri-meno-
pausal age, test sensitivity, specificity, PPV, and NPV were
58.8%, 95.0%, 49.1%, and 91.7%, respectively, with a
cut-off score of 12. The results of our study demonstrated
that screening for depression via the Internet may have
similar validity as screening tests conducted in writing,
most of which have been reported to be highly sensitive
and specific [40].
Despite the satisfying results of the present examination
of the reliability and validity of the ISP-D, the study has
several limitations. The first limitation of our study is the
Table 1: Demographic data for the ISP-D test, retest, and validity samples
Variables Test sample (n = 579) Retest sample (n = 184)* Validity sample (n = 55)† 
Age (years)  NS P < 0.001
Mean ± SD 26.5 ± 6.6 26.2 ± 6.6 29.7 ± 7.5
Range 18–52 18–49 18–51
Education (years) NS NS
Mean ± SD 14.9 ± 2.1 15.2 ± 1.9 15.3 ± 2.0
Range 0–21 9–21 9–18
%%%
Sex NS NS
Female 72.7 77.7 76.4
Male 27.3 22.3 23.6
Marital status NS NS
Married 18 18.5 23.6
Single 82 81.5 76.4
Employment status NS P = 0.027
Employed 51.8 48.4 67.3
Student 39.4 44.6 23.6
Unemployed 8.8 7.1 9.1
* Statistical comparisons were made between retest responders and non-responders. All p values > 0.05.
† Statistical comparisons were made between validity responders and non-responders. P value was shown when p < 0.05.
NS: no significant statistical difference.
ISP-D: Internet-based Self-assessment Program for Depression.BMC Psychiatry 2007, 7:12 http://www.biomedcentral.com/1471-244X/7/12
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potential for a self-selected effect. The high prevalence of
MDD, MinD, and SSD in the study may be due to a self-
selected effect of the participants. That is, people who had
depressive symptoms may have been more motivated to
participate in the study than non-depressed persons in the
general population. On the other hand, many severely
depressed patients may not have access to the Internet.
The self-selected effect was apparent in the demographic
characteristics of our study sample, with the majority of
participants being young, single, well educated women.
This sampling bias limits our ability to generalize our
findings to the general population. The second limitation
is the relatively low response rate in the test-retest reliabil-
ity study, a characteristic inherent to Internet studies
[41,42]. Importantly, our statistical analysis showed that
the sociodemographic characteristics did not affect the
agreement of the test-retest reliability or the validity of the
ISP-D, despite these limitations. The third limitation is
Table 2: ISP-D test-retest diagnosis reliabilities by test-retest time interval
(A)Within 2 weeks of test-retest time interval
ND SSD MinD MDD Total no.
ND 12 2 0 0 14
SSD 08 0 1 9
MinD 30 0 2 5
MDD 10 1 2 93 1
Total no. 16 10 1 32 59
Weighted κ 0.801
(B) Between 2 and 4 weeks of test-retest time interval
ND SSD MinD MDD Total no.
ND 21 4 2 4 31
SSD 79 2 5 2 3
MinD 21 2 2 7
MDD 52 2 1 62 5
Total no. 35 16 8 27 86
Weighted κ 0.432
(C) Greater than 4 weeks of test-retest time interval
ND SSD MinD MDD Total no.
ND 44 0 2 1 0
SSD 27 0 0 9
MinD 11 2 0 4
MDD 03 4 9 1 6
Total no. 71 5 6 1 13 9
Weighted κ 0.509
ISP-D: Internet-based Self-assessment Program for Depression; MDD: major depressive disorder; MinD: minor depressive disorder; SSD: 
subsyndromal depressive disorder; ND: no depression specified.
Table 4: Comparison of ISP-D diagnoses and psychiatrists' diagnoses for major depressive disorder
ISP-D diagnoses Psychiatrists' diagnosis Total
Depressed Not depressed
Yes  18 9 27
No 42 4 2 8
Total 22 33 55
ISP-D: Internet-based Self-assessment Program for Depression
Sensitivity = 81.8%; Specificity = 72.7%; Positive predictive value = 66.7%; Negative predictive value = 85.7%.BMC Psychiatry 2007, 7:12 http://www.biomedcentral.com/1471-244X/7/12
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that the kappa statistics for each diagnosis was recoded
and recalculated. The interpretation should be cautious
because of possible recoding bias.
Because the mean Internet interview time for the ISP-D
was relatively short, and participants did not need to go to
a clinic, the ISP-D may be useful as an auxiliary tool for
screening or follow-up of depression as an alternative to
the face-to-face interview. There is little additional cost to
online interviews beyond maintenance of the system on
the server. Computer-aided interviewing gives standard-
ized information about a patient's psychopathology and
diagnosis. It allows patients to work at their own pace and
is available whenever a computer terminal is available.
Furthermore, results can be scored and presented to the
patients and/or clinicians immediately. Indeed the stand-
ardized manner of administration and scoring of compu-
ter-administered rating scales may actually improve
reliability and insure greater completeness of the informa-
tion gathered [18].
The ISP-D can generate personalized reports, which sum-
marize each individual's responses and possible diagnos-
tic categories. The automatically generated final report
was designed to be printed and shared with a health care
professional. In addition, links to related Internet articles
and information about resources such as clinics and hos-
pitals, virtual clinics, and online groups can be provided
when participants have positive findings.
Conclusion
To our knowledge, this study was the first to investigate
both the reliability and validity of a Web-based depres-
sion program. We found that the test-retest reliability of
the ISP-D was excellent within a 2-week interval and its
criterion validity was comparable to that observed with
written tests. The current study offers Internet users an
alternative way to assess depression by oneself in a short
amount of time. The ISP-D provides a continuously avail-
able, inexpensive, and easily maintained depression
screening method that is accessible to a large number of
individuals across a broad geographic area. In order to
broaden the application of the ISP-D, further studies con-
ducted with various populations (outpatients, inpatients
etc.) in larger sample sizes (especially for validity) should
be conducted.
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Additional material
Additional file 1
English translation of questions in the Internet-based Self-assessment Pro-
gram for Depression (ISP-D). The English translation of ISP-D is prelim-
inary and is intended for the ease of journal readers to understand the 
original Chinese version of ISP-D.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
244X-7-12-S1.doc]
Table 3: ISP-D test-retest reliabilities for depressive symptoms by test-retest time interval
Depressive symptoms κ (agreement) by time interval
<2 weeks (N = 59) ≥2 to ≤4 weeks (N = 86) >4 weeks (N = 39)
Depressed mood 0.458 (72.9%) 0.360 (73.3%) 0.412 (71.8%)
Diminished interest or pleasure 0.759 (88.1%) 0.557 (77.9%) 0.438 (71.8%)
Decreased appetite 0.551 (79.7%) 0.622 (83.7%) 0.206 (59.0%)
Insomnia or hypersomnia 0.594 (79.7%) 0.541 (77.9%) 0.584 (79.5%)
Activity disturbance 0.433 (72.9%) 0.422 (70.9%) 0.227 (61.5%)
Fatigue or loss of energy 0.791 (93.2%) 0.544 (77.9%) 0.379 (76.9%)
Worthlessness or excessive guilt 0.423 (71.2%) 0.564 (79.1%) 0.734 (87.2%)
Diminished ability to think or concentrate  0.568 (84.7%) 0.546 (79.1%) 0.554 (79.5%)
Thoughts of death 0.829 (91.5%) 0.334 (70.9%) 0.556 (79.5%)
ISP-D: Internet-based Self-assessment Program for Depression.
The presence of depressive symptoms was defined as fulfilling the symptomatic criteria of DSM-IVBMC Psychiatry 2007, 7:12 http://www.biomedcentral.com/1471-244X/7/12
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